Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.35 – $8.36
80% from low
No one on the platform currently holds ATHA.
No tracked institution reports a position in ATHA as of their last filing.
No one on the platform has traded ATHA yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $13M | — | $-4.87 | $-5.03–$-4.71 | — | 2 |
| 2027 | $0 | -100.0% | $-0.40 | $-0.40–$-0.40 | — | 1 |
| 2028 | $0 | — | $-0.43 | $-0.43–$-0.43 | — | 1 |
| 2029 | $0 | — | $-0.45 | $-0.45–$-0.45 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-07 | $-1.90 | $-1.73 | +8.9% |
| 2026-02-25 | $-0.58 | $-3.90 | -577.8% |
| 2025-11-06 | $-1.06 | $-1.68 | -58.5% |
| 2025-08-07 | $-1.80 | $-1.80 | +0.0% |
| 2025-05-09 | $-0.20 | $-0.23 | -15.0% |
| 2025-02-27 | $-0.23 | $-0.39 | -69.6% |
| 2024-11-07 | $-0.80 | $-0.75 | +6.3% |
| 2024-08-01 | $-0.75 |
| $-0.70 |
| +6.7% |
| $8M |
| — |
| DAREDare Bioscience, Inc. | $1.37 | -4.86% | $21M | — |
| FBLGFibroBiologics, Inc. Common Stock | $1.15 | +3.60% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry